
Alexander Tsankov, PhD
- ASSISTANT PROFESSOR | Genetics and Genomic Sciences
Research Topics:
Biomedical Informatics, Cancer, Clinical Genomics, Computational Biology, Epigenomics, Lung, Regeneration, Stem Cells
The Tsankov lab’s overall vision is to use genomics to build data-driven, predictive models that improve diagnosis, find new drugable pathways, and personalize treatment of patients with lung cancer and respiratory diseases. We utilize state-of-the-art single cell transcriptomic, epigenetic, and spatial technologies on clinical samples from patients and advanced computational analysis with the goal of unraveling the underlying regulatory mechanisms in normal lung tissue homeostasis and lung disease. Of particular interest is how the interactions of the lung epithelium with the immune and stromal microenvironment change between normal and diseased states. For more information, please the visit the Tsankov Laboratory
Multi-Disciplinary Training Areas
Artificial Intelligence and Emerging Technologies in Medicine [AIET], Cancer Biology [CAB], Development Regeneration and Stem Cells [DRS], Genetics and Genomic Sciences [GGS]Education
PhD, Massachusetts Institute of Technology
Postdoctoral Fellow, Harvard University and Broad Institute
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Tsankov did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.